(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of 6.34% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 19.34%.
Rockwell Medical's revenue in 2026 is $69,389,000.On average, 4 Wall Street analysts forecast RMTI's revenue for 2026 to be $297,395,921, with the lowest RMTI revenue forecast at $285,155,399, and the highest RMTI revenue forecast at $306,762,722.
In 2027, RMTI is forecast to generate $321,296,578 in revenue, with the lowest revenue forecast at $300,628,354 and the highest revenue forecast at $339,389,336.